95 related articles for article (PubMed ID: 496871)
1. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
[No Abstract] [Full Text] [Related]
2. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
[No Abstract] [Full Text] [Related]
3. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383
[TBL] [Abstract][Full Text] [Related]
4. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
Forconi S; Guerrini M
Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
[No Abstract] [Full Text] [Related]
5. [Effect of troxerutin on platelet aggregation in patients with arteriosclerosis].
Myśliwiec M; Bodzenta A
Pol Tyg Lek; 1983 Oct; 38(44):1367-8. PubMed ID: 6674961
[No Abstract] [Full Text] [Related]
6. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
Mann RJ
Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
[No Abstract] [Full Text] [Related]
7. [Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency].
Stemmer R; Furderer CR
Phlebologie; 1986; 39(4):995-1003. PubMed ID: 3562569
[TBL] [Abstract][Full Text] [Related]
8. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Roztocil K; Oliva I; Prerovský I; Linhart J
Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
Stegmann W; Hubner K; Deichmann B; Muller B
Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
[TBL] [Abstract][Full Text] [Related]
10. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
Bopp J
Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
[No Abstract] [Full Text] [Related]
11. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides].
Annoni F; Boccasanta P; Chiurazzi D; Mozzi E; Oberhauser V
Minerva Med; 1986 Sep; 77(37):1663-8. PubMed ID: 3531924
[TBL] [Abstract][Full Text] [Related]
13. [Medical treatment of hemorrhoidal varices: comparison of treatments].
Bonfanti R; Corti T; Villa E
Clin Ter; 1978 Jan; 84(2):151-66. PubMed ID: 148345
[No Abstract] [Full Text] [Related]
14. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
Becker HM; Niedermaier G; Orend KH
Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
[No Abstract] [Full Text] [Related]
15. Effect of o-(beta-hydroxyethyl)-rutosides on the microrheology of human blood under defined flow conditions.
Schmid-Schönbein H; Volger E; Weiss J; Brandhuber M
Vasa; 1975; 4(3):263-70. PubMed ID: 1179829
[No Abstract] [Full Text] [Related]
16. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
17. Results of a clinical trial with a new gel--association of a flavonoid and a heparinoid--in sports injuries.
Lisý Z; Vrbicky B
Schweiz Z Sportmed; 1988 Jun; 36(2):91-3. PubMed ID: 2456611
[No Abstract] [Full Text] [Related]
18. [Platelet aggregation in atherosclerotic disease after administration of lysine acetylsalicylate].
Evangelisti GB; Faggioli F; Garagnani A; Lama G
Minerva Cardioangiol; 1978 Jun; 26(6):447-60. PubMed ID: 673198
[No Abstract] [Full Text] [Related]
19. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
Craveri A; Colombo L; Cristina M; Coloru M; De Angeli B; Lanfredini M
Clin Ter; 1991 Jan; 136(1):23-9. PubMed ID: 1826869
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
